What is the purpose of the SPS3 study?
The purpose of the SPS3 study is to investigate the effectiveness of different treatments for secondary prevention of small subcortical strokes. The study is based on the hypothesis that different treatments may be more effective in preventing these types of strokes than no treatment at all. The study is conducted by the SPS3 Investigators and includes a variety of outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack, as well as cognitive impairment in lacunar strokes. Additionally, the study also assesses the natural history of lacunar infarction and compares the risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Furthermore, the study also looks into the Cilostazol stroke prevention study, which is a placebo-controlled double-blind trial for secondary prevention of cerebral infarction.  